| Product Code: ETC335010 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Novobiocin is an antibiotic used in the medical field, and its market in Vietnam has seen gradual growth due to the country`s expanding healthcare sector. Novobiocin is primarily used for its antibacterial properties and is administered in various forms, including injections and topical applications. As healthcare infrastructure continues to improve and awareness of antibiotic therapies increases, the novobiocin market is expected to see sustained growth. The market comprises both domestic pharmaceutical companies and international players who supply novobiocin and related products to hospitals and healthcare institutions.
The novobiocin market in Vietnam is experiencing growth due to several drivers. Novobiocin, an antibiotic used in the medical field, is witnessing increasing demand due to the rising incidence of bacterial infections and the need for effective antibiotics. The growing healthcare infrastructure and investment in pharmaceutical research and development are also contributing to the expansion of the novobiocin market. Moreover, as Vietnam aims to enhance its pharmaceutical manufacturing capabilities, there is a greater need for active pharmaceutical ingredients like novobiocin. Additionally, healthcare professionals are increasingly prescribing novobiocin for various bacterial infections, further boosting its demand. These factors, combined with a greater awareness of healthcare and hygiene, are driving the novobiocin market in Vietnam.
The novobiocin market in Vietnam faces challenges related to regulatory compliance and product safety. Novobiocin is an antibiotic used in healthcare, and stringent regulations govern its production, distribution, and use. Ensuring product quality and compliance with regulations can be expensive and time-consuming for manufacturers. Additionally, antibiotic resistance is a growing concern globally, leading to restrictions on antibiotic use. The market must adapt to evolving regulations and invest in research to address antibiotic resistance issues.
The novobiocin market in Vietnam witnessed disruptions due to the COVID-19 pandemic. Novobiocin, an antibiotic used in healthcare settings, faced increased demand during the initial stages of the pandemic. However, the global supply chain was impacted, leading to shortages in the availability of pharmaceuticals, including novobiocin. Hospitals and healthcare facilities faced challenges in sourcing essential medicines, and pharmaceutical companies grappled with production interruptions and regulatory changes. As the healthcare sector prioritized pandemic response, the novobiocin market saw fluctuations in supply and demand. The market`s stability improved as pharmaceutical companies adapted to pandemic-related challenges and increased their production capacity.
Leading pharmaceutical companies like DHG Pharmaceutical Joint Stock Company and Domesco Medical Import-Export Corporation dominate the novobiocin market in Vietnam. They manufacture and distribute pharmaceutical products, including novobiocin.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Novobiocin Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Novobiocin Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Novobiocin Market - Industry Life Cycle |
3.4 Vietnam Novobiocin Market - Porter's Five Forces |
3.5 Vietnam Novobiocin Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Vietnam Novobiocin Market Revenues & Volume Share, By Applications, 2021 & 2031F |
4 Vietnam Novobiocin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Vietnam |
4.2.2 Growing awareness about the benefits of novobiocin in treating infections |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and sale of novobiocin |
4.3.2 Competition from alternative antibiotics in the market |
5 Vietnam Novobiocin Market Trends |
6 Vietnam Novobiocin Market, By Types |
6.1 Vietnam Novobiocin Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Novobiocin Market Revenues & Volume, By Types, 2021-2031F |
6.1.3 Vietnam Novobiocin Market Revenues & Volume, By More Than 95%, 2021-2031F |
6.1.4 Vietnam Novobiocin Market Revenues & Volume, By 90% - 95%., 2021-2031F |
6.1.5 Vietnam Novobiocin Market Revenues & Volume, By Less Than 90%, 2021-2031F |
6.2 Vietnam Novobiocin Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Novobiocin Market Revenues & Volume, By Eye Drops, 2021-2031F |
6.2.3 Vietnam Novobiocin Market Revenues & Volume, By Compound Ointment, 2021-2031F |
6.2.4 Vietnam Novobiocin Market Revenues & Volume, By Sulfate Tablets, 2021-2031F |
6.2.5 Vietnam Novobiocin Market Revenues & Volume, By Other, 2021-2031F |
7 Vietnam Novobiocin Market Import-Export Trade Statistics |
7.1 Vietnam Novobiocin Market Export to Major Countries |
7.2 Vietnam Novobiocin Market Imports from Major Countries |
8 Vietnam Novobiocin Market Key Performance Indicators |
8.1 Number of novobiocin prescriptions by healthcare professionals |
8.2 Patient adherence rate to novobiocin treatment regimens |
8.3 Number of clinical trials testing novobiocin efficacy and safety |
9 Vietnam Novobiocin Market - Opportunity Assessment |
9.1 Vietnam Novobiocin Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Vietnam Novobiocin Market Opportunity Assessment, By Applications, 2021 & 2031F |
10 Vietnam Novobiocin Market - Competitive Landscape |
10.1 Vietnam Novobiocin Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Novobiocin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here